FRI0367 Fatigue is an Internationally Valid Concept: The Bristol RA Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) in 6 EU Countries. (9th June 2015)

• Record Type: Journal Article
• Authors: Hewlett, S.; Nicklin, J.; Kirwan, J.; Cramp, F.; Dures, E.; Greenwood, R.; Fransen, J.; Englbrecht, M.; Schett, G.; Petersson, I.; Hagel, S.; Carmona, L.; Redondo, M.; Molto, A.; Bode, C.; van de Laar, M.; Gossec, L.
• Is Part Of: Annals of the rheumatic diseases. Volume 74(2015)Supplement 2
• Page Start: 559
• Page End: 559
• Publication Date: 2015-06-09
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2015-eular.2339
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: The 20-item BRAF-MDQ was developed in the UK to measure RA fatigue, with a total score and 4 distinct subscales reflecting different fatigue concepts; there are 35 translations. If the translations adequately capture these concepts, then their internal factor structure should be similar; if not this would indicate important cultural differences in fatigue perception, requiring country-specific scoring. Criterion and construct validity have not yet been examined outside the UK. Objectives: To test the internal structure, criterion and construct validity of the BRAF-MDQ in France (F), Germany (G), Netherlands (N), Spain (Sp), Sweden (Sw) and UK. Methods: 100-200 RA patients in each country completed the BRAF-MDQ (sufficient for reliable factor analysis by country), the RA Impact of Disease (RAID) and the SF-36. BRAF-MDQ internal factor structure was tested by confirmatory factor analysis of the original 4 factors; internal consistency by Cronbach's alpha; criterion validity by Spearman's correlation with RAID and SF-36 vitality subscale; and construct validity by correlation with the remaining 7 SF-36 domains. Results: 1276 patients participated (F 206, G 216, N 317, Sp 157, Sw 170, UK 210). Overall, 76% were female; 10% <40 yrs old and 50% ≥60 yrs; 25.5% disease duration <5 yrs, with no major differences between countries. Overall mean BRAF-MDQ (0-70) was 26.04 (SD 16.18, range 0-70), country range 22.02 (G) to 34.19 (UK). The original 4-factor structure was upheld in each country with all items loading >0.7: Physical fatigue factor 0.749-0.910, Living with fatigue 0.705-0.899, Cognitive fatigue 0.797-0.959 and Emotional fatigue 0.793-0.919. The factor structure was upheld in 476/480 further tests comprising the 4 factors tested in 20 randomly selected subsets of 50% of patients per country (bootstrapping). Internal consistency was strong in all 6 countries for the total BRAF-MDQ: Cronbach's alpha 0.932-0.954. Subscales were also internally consistent in all 6 countries: Physical 0.75-0.791; Living 0.918-0.943; Cognition 0.912-0.955, Emotion 0.852-0.893. Criterion validity was shown in the toal sample and all 6 countries by high correlations amongst the BRAF subscales (0.367-0.986); high correlations of the total BRAF with the BRAF subscales (r=0.815–0.928); and of the total BRAF and subscales with both the RAID fatigue item (0.512-0.878) and SF-36 Vitality item (-0.501 to -0.830). Construct validity was shown in all 6 countries and in the total sample by appropriate correlations between the total BRAF, subscales and the remaining 7 SF-36 health domains: r=-0.223 (Sw, Emotion with Physical Function) to -0.760. Conclusions: The BRAF-MDQ has an internal factor structure that holds across 6 EU countries, supporting its conceptual validity internationally. It has evidence for internal consistency, criterion and construct validity in 6 countries, further supporting its increasingly widespread use. Disclosure of Interest: None declared